Sukumaran, Vijayakumar
Olmesartan attenuates the development of heart failure after experimental autoimmune myocarditis in rats through the modulation of ANG 1-7 mas receptor. [electronic resource]
- Molecular and cellular endocrinology Apr 2012
- 208-19 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
ISSN: 1872-8057
Standard No.: 10.1016/j.mce.2011.12.010 doi
Subjects--Topical Terms: Angiotensin I--genetics Angiotensin II Type 1 Receptor Blockers--pharmacology Angiotensin-Converting Enzyme 2 Animals Apoptosis--drug effects Autoimmune Diseases--drug therapy Cardiotonic Agents--pharmacology Endoplasmic Reticulum Stress--drug effects Heart Failure--drug therapy Imidazoles--pharmacology Inflammation--drug therapy JNK Mitogen-Activated Protein Kinases--biosynthesis Membrane Glycoproteins Myocarditis--drug therapy NADPH Oxidase 4 NADPH Oxidases--biosynthesis Oxidative Stress--drug effects Peptide Fragments--genetics Peptidyl-Dipeptidase A--biosynthesis Phosphatidylinositol 3-Kinases--biosynthesis Phosphoproteins--biosynthesis Proto-Oncogene Proteins c-akt--biosynthesis RNA, Messenger--biosynthesis Rats Rats, Inbred Lew Receptor, Angiotensin, Type 1--metabolism Receptors, Interleukin-1 Tetrazoles--pharmacology p38 Mitogen-Activated Protein Kinases--biosynthesis